Medical News

RSS

Researchers closer to understanding complicated brain chemistry behind Alzheimer's disease

Researchers at the University of Melbourne have discovered that a protein involved in the progression of Alzheimer's disease also has properties that could be helpful for human health.

3 Aug 2015

Redox equilibrium may help identify new diagnostic biomarkers for ageing, neurodegenerative processes

The question of why we age is one of the most fascinating questions for humankind, but nothing close to a satisfactory answer has been found to date.

3 Aug 2015

Integrated treatment required for diabetes-eating disorder combination

As they reach their teens, many with type 1 diabetes discover that the disease provides a secret weapon for losing weight. By restricting or reducing the amount of insulin they inject, they can eat just about anything they want and control their weight.

3 Aug 2015

Research shows specific routes of administration can predict risk of drug addiction

Abstinence is the best way to avoid drug addiction. But in many societies, drug use is the norm, not the exception, especially by youth.

3 Aug 2015

Atomic level images reveal how neuropeptide hormone neurotensin may activate its receptors

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells.

3 Aug 2015

U-M’s Taubman Health Sciences Library reopens as transformed space for learning, teaching

The books moved out two years ago, and the construction crews moved in. And today, the University of Michigan's Taubman Health Sciences Library reopens as a transformed space for learning, teaching and gathering.

3 Aug 2015

Lancet Series examines enduring radiological, psychological impact of nuclear disasters

On the 70th anniversary of the atomic bombs in Hiroshima and Nagasaki, a three-part Series published in The Lancet looks at the enduring radiological and psychological impact of nuclear disasters, including the most recent accident at the Fukushima Daiichi nuclear power plant in Japan in 2011.

3 Aug 2015

First large field trial shows VSV-ZEBOV is effective against Ebola

A vaccine against the Ebola virus, tested in West Africa for the first time in a field trial, has proved to be effective. People who had come into close contact with someone recently infected, and who are therefore at particularly high risk, were vaccinated.

3 Aug 2015

Childhood cancer cells produce molecule that affects body's immune system to fight disease

Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body's immune cells, leaving them too physically drained to fight the disease, according to new research published in the journal Cancer Research today (Saturday).

3 Aug 2015

3D-printed models of children's brain anatomy help reduce operative risk of complex procedures

Boston Children's Hospital physicians report the first cases of children benefiting from 3D printing of their anatomy before undergoing high-risk brain procedures.

3 Aug 2015

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

The BRCA gene encodes for the BRCA proteins, BRCA1 and BRCA2. These proteins are very important in repairing DNA, which they do by correcting double-stranded breaks.

2 Aug 2015

Tests show VSV-ZEBOV vaccine safe and effective against Ebola

Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.

31 Jul 2015

New IMA device could improve diagnosis, treatment of chronic musculoskeletal pain

More than 100 million people across Europe suffer from chronic musculoskeletal pain, with an estimated 40 per cent undiagnosed. Ageing populations throughout Europe means that this only going to increase in the coming years.

31 Jul 2015

FDA accepts Mundipharma EDO's Investigational New Drug Application for EDO-S101

Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.

31 Jul 2015

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.

31 Jul 2015

Guinea Phase III trial shows VSV-EBOV vaccine highly effective against Ebola

Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola.

31 Jul 2015

Study evaluates costs and benefits of medical board recertification for improving healthcare quality

Many physicians are pushing back against or debating new requirements for maintaining medical board certifications, which affect more than 250,000 physicians nationwide. Now, a new study by UC San Francisco and Stanford University researchers concludes that the cost of implementing the most recent requirements will be an estimated $5.7 billion over the next 10 years.

31 Jul 2015

University of Southampton research finds that electric fields alter behaviour of fruit flies

A new piece of research led by the University of Southampton has found that the behaviour of fruit flies, which are commonly used in laboratory experiments, is altered by electric fields.

31 Jul 2015

Teen scientist finds solution to tackle water quality issues

For some of us it was an exciting time of creative experimentation. For others it was a time of botched and badly displayed data. For 16-year-old Maria Elena Grimmett, it's a blast. And she isn't peddling baking soda and vinegar volcanoes. Grimmett is tackling serious water quality issues that threaten the health of rivers, streams and groundwater. When she was just 14 years old, Grimmett was the youngest person published in the Journal of Environmental Quality.

31 Jul 2015

Reducing incorrect gene expression can extend lifespan of cells

Working with yeast and worms, researchers found that incorrect gene expression is a hallmark of aged cells and that reducing such "noise" extends lifespan in these organisms. The team published their findings this month in Genes & Development.

31 Jul 2015

Medical News

Researchers closer to understanding complicated brain chemistry behind Alzheimer's disease

Redox equilibrium may help identify new diagnostic biomarkers for ageing, neurodegenerative processes

Integrated treatment required for diabetes-eating disorder combination

Research shows specific routes of administration can predict risk of drug addiction

Atomic level images reveal how neuropeptide hormone neurotensin may activate its receptors

U-M’s Taubman Health Sciences Library reopens as transformed space for learning, teaching

Lancet Series examines enduring radiological, psychological impact of nuclear disasters

First large field trial shows VSV-ZEBOV is effective against Ebola

Childhood cancer cells produce molecule that affects body's immune system to fight disease

3D-printed models of children's brain anatomy help reduce operative risk of complex procedures

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

Tests show VSV-ZEBOV vaccine safe and effective against Ebola

New IMA device could improve diagnosis, treatment of chronic musculoskeletal pain

FDA accepts Mundipharma EDO's Investigational New Drug Application for EDO-S101

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Guinea Phase III trial shows VSV-EBOV vaccine highly effective against Ebola

Study evaluates costs and benefits of medical board recertification for improving healthcare quality

University of Southampton research finds that electric fields alter behaviour of fruit flies

Teen scientist finds solution to tackle water quality issues

Reducing incorrect gene expression can extend lifespan of cells

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News